Bio-thera Solutions
Clinical trials sponsored by Bio-thera Solutions, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New keytruda copycat tested in lung cancer patients after surgery Results expected Feb 2027 (estimated)
- New hope for diabetes-related vision loss: experimental drug faces final test Results expected Apr 2027 (estimated)
- New targeted drug BAT8008 enters human testing for Hard-to-Treat cancers Results expected May 2027 (estimated)
-
New hope for diabetes-related vision loss: experimental drug faces final test
Disease control Recruiting nowThis study tests a new eye medication called BAT5906 against an approved drug (Lucentis) for people with diabetic macular edema, a condition that causes vision loss in diabetes. About 406 adults with type 1 or type 2 diabetes will receive injections into the eye and be followed f…
Phase 3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug aims to stop kidney disease relapses
Disease control Recruiting nowThis study tests a drug called BAT4406F in people with two rare kidney conditions: Minimal Change Disease and Focal Segmental Glomerulosclerosis. The goal is to see if it can reduce protein in the urine and prevent the disease from coming back. About 192 participants will receive…
Phase 2/3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New targeted drug BAT8008 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug called BAT8008 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to target a protein called Trop2 found on many cancer cells. The main goals are to check safety, find the best dos…
Phase 1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC